Patents by Inventor Michael Brasch

Michael Brasch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020172997
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Application
    Filed: July 19, 2001
    Publication date: November 21, 2002
    Inventors: James L. Hartley, Michael A. Brasch, Gary F. Temple, Donna K. Fox
  • Publication number: 20020094574
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Application
    Filed: May 16, 2001
    Publication date: July 18, 2002
    Inventors: James L. Hartley, Michael A. Brasch, Gary F. Temple, Donna K. Fox
  • Publication number: 20020007051
    Abstract: The present invention provides compositions and methods for recombinational cloning. The compositions include vectors having multiple recombination sites with unique specificity. The methods permit the simultaneous cloning of two or more different nucleic acid molecules. In some embodiments the molecules are fused together while in other embodiments the molecules are inserted into distinct sites in a vector. The invention also generally provides for linking or joining through recombination a number of molecules and/or compounds (e.g., chemical compounds, drugs, proteins or peptides, lipids, nucleic acids, carbohydrates, etc.) which may be the same or different. Such molecules and/or compounds or combinations of such molecules and/or compounds can also be bound through recombination to various structures or supports according to the invention.
    Type: Application
    Filed: December 11, 2000
    Publication date: January 17, 2002
    Inventors: David Cheo, Michael A. Brasch, Gary F. Temple, James L. Hartley, Devon R. N. Byrd
  • Patent number: 6277608
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Grant
    Filed: April 22, 1999
    Date of Patent: August 21, 2001
    Assignee: Invitrogen Corporation
    Inventors: James L. Hartley, Michael A. Brasch, Gary F. Temple, Donna K. Fox
  • Patent number: 6270969
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Grant
    Filed: January 20, 1999
    Date of Patent: August 7, 2001
    Assignee: Invitrogen Corporation
    Inventors: James L. Hartley, Michael A. Brasch
  • Patent number: 6171861
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Grant
    Filed: January 12, 1998
    Date of Patent: January 9, 2001
    Assignee: Life Technologies, Inc.
    Inventors: James L. Hartley, Michael A. Brasch
  • Patent number: 6143557
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Grant
    Filed: January 20, 1999
    Date of Patent: November 7, 2000
    Assignee: Life Technologies, Inc.
    Inventors: James L. Hartley, Michael A. Brasch
  • Patent number: 5888732
    Abstract: Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
    Type: Grant
    Filed: June 7, 1996
    Date of Patent: March 30, 1999
    Assignee: Life Technologies, Inc.
    Inventors: James L. Hartley, Michael A. Brasch